multicenter
controlled trial
early
blockade
renin-angiotensin system
patients
type 1 diabetes
normoalbuminuria
retard
progression
nephropathy
mechanism(s)
pathogenesis
early
diabetic nephropathy
endothelial-mesenchymal-transition
EndoMT
development
renal interstitial fibrosis
microalbuminuria
mice
streptozotocin
diabetes
study
blocking
EndoMT
reduces
early development
diabetic nephropathy
